China targets fake drugs and bribery in nationwide probe

07/17/2013 | AlertNet

China's State Food and Drug Administration has announced a six-month national campaign aimed at shutting down illegal online drug retailers and stopping sales of fake traditional Chinese medicines. The action comes days after authorities accused GlaxoSmithKline of bribing doctors and health officials to try to boost sales of its drugs by using almost $500 million that was transferred through travel agencies and consultants. China has conducted campaigns in the past to stop false advertising and the sale of counterfeit drugs.

View Full Article in:

AlertNet

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Product Development Manager, Disposable Medical Products
ASAHI INTECC, Orange County CA R&D Center
Santa Ana, CA
Neurovascular Intervention Product Sales Rep, North East
ASAHI INTECC
Multiple Locations, SL_Multiple Locations
Vice President of Regulatory Affairs
Pentec Health
Boothwyn, PA
Sr Coordinator Clinical Research (US/TA/00/0073/SL) - 1400000AQX
Abbott
Santa Clara, CA
Senior Director, Biostatistics
Edwards Lifesciences
Irvine, CA